Transforming patients’ lives by leading innovation in nuclear medicine

At Advanced Accelerator Applications, we are reimagining nuclear medicine and cancer care. Our mission is to transform patients’ lives by developing and delivering targeted radioligand therapies and precision diagnostic solutions for oncology.

Visit at the Adacap state-of-the-art manufacturing site in Salamanca, Spain.

Expanding our patient reach in Spain with the new Salamanca site

Turning the power of nuclear technology into a medical force

Not your grandparents’ nuclear medicine

Novartis RLT manufacturing facility in Indianapolis, Indiana

Radioligand therapy: delivering now, building for the future

About Advanced Accelerator Applications


Associates globally



1 of the 4

platforms of the Novartis Bold4Cure strategy

Founded in 2002, AAA has a strong legacy as a pioneer in nuclear medicine.
We believe targeted radioligand therapy has the potential to be broadly used in many different tumor types.

“This is a very exciting time in AAA’s development. I believe in the potential of radioligand therapy to transform patients’ lives and I am committed to exploring this therapeutic approach in multiple tumor types.”

Sidonie Golombowski-Daffner
President of AAA

Women in Oncology